Overview

Trial Comparing Patching Versus Atropine for Amblyopia in 7 to < 13 Year Olds

Status:
Completed
Trial end date:
2008-01-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is: - To compare the effectiveness of weekend atropine plus near activities and daily patching plus near activities for moderate amblyopia (20/40 to 20/100) and severe amblyopia (20/125 to 20/400) in improving vision in the amblyopic eye of 7 to <13 year olds. - To determine the maximum improvement in vision of the amblyopic eye with each treatment. - To determine whether amblyopia is associated with structural abnormalities of optic nerve fiber layer.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Jaeb Center for Health Research
Collaborator:
National Eye Institute (NEI)
Treatments:
Atropine
Criteria
Inclusion Criteria:

- Age 7 to 12 years old (inclusive)

- Amblyopia associated with strabismus, anisometropia, or both

- Visual acuity in the amblyopic eye 19 to 71 letters on Electronic Early Treatment
Diabetic Retinopathy Study (E-ETDRSĀ©) (20/40 to 20/400 inclusive)

- Visual acuity in the sound eye 79 letters or better on E-ETDRSĀ© (20/25 or better)

- Interocular difference >=15 letters (3 lines)

- Spectacles, if needed, worn for at least 16 weeks or visual acuity documented to be
stable

Inclusion Criteria for Optional Ancillary Study:

- Enrolled into the main study

- Refractive error in both eyes between -0.25 and +5.00D, inclusive (to avoid the need
to adjust for refractive error)

- Birth weight >1500 grams

- No history of Central Nervous System (CNS) disease (e.g. intraventricular hemorrhage
(IVH), periventricular leukomalacia (PVL), meningitis, developmental abnormalities of
the brain, hydrocephalus, cerebral palsy, hypoxic ischemic encephalopathy

Exclusion Criteria:

- Amblyopia treatment (other than spectacles) in the last 6 months

- Myopia (more than -0.25D spherical equivalent) in either eye